Cancer Data Analysis Firm COTA Raises $3.7M | GenomeWeb

NEW YORK (GenomeWeb) – Cancer data analysis firm COTA today said that it has raised $3.7 million toward a targeted $7 million in a Series A financing round.

Horizon Healthcare Services led the round and was joined by Med-Metrix. The funds will be used to further develop COTA's cloud-based platform, hire new staff, and launch the company's first commercial product.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.